Thermotherapy · Featured

Dose-Controlled Cold Therapy

A comprehensive heat-transfer system for continuous study

Research white paper · for clinical review of Temp°IQ thermal data·← All white papers

Interval icing — twenty minutes on, then off, repeated — is among the most universal instructions in musculoskeletal care. This paper asks a simple question with a practical answer: how much of that protocol reflects physiology, and how much reflects the limitations of ice as a tool? We argue the on/off interval is, in large part, an artifact of an uncontrollable cooling source, and that a device able to remove a measured, regulated amount of heat reframes cryotherapy from a timed ritual into a titratable, measurable dose — and lets us map a dose–response that has never been measurable.

The therapeutic target is a temperature, held over time

Across the literature, the active variable in cryotherapy is tissue temperature, and the benefit depends on reaching and maintaining a therapeutic reduction [5,6]. Bleakley's randomized comparison found that an intermittent protocol (10 minutes on, 10 off) produced less pain than a standard continuous 20-minute application, and attributed the difference to intermittent application's ability to bring tissue temperature to optimal therapeutic levels [1]. Kwiecien and colleagues make the limitation explicit: traditional ice has "inadequate duration of application," must be repeated, and its effectiveness is "dependent upon its ability to maintain a reduction in muscle temperature" — with sustained 15 °C phase-change cooling applied for 3–6 hours succeeding where brief ice does not [6].

Why the clock, not the thermometer, governs icing

Ice is a fixed, very cold source (~0 °C) with an uncontrollable extraction rate. Two consequences follow. First, exposure is capped by time to prevent cold injury: temporary nerve palsies and frostbite are recognized complications, and the classic guidance is simply not to ice for more than about 30 minutes and to guard superficial nerves [4,5]. Second, because the rate cannot be dialed, clinicians manage dose by duration and repetition rather than by holding a target temperature. The interval is, in effect, a safety fuse and a workaround — not a derived physiological optimum.

The optimum is unknown — and largely unmeasured

Systematic reviews are consistent on two points: there is no established optimal mode or duration of cryotherapy, and the evidence base is weak [2,3]. Tellingly, reviewers note that the actual surface temperature delivered by the cooling device was usually not even reported [2]. The mode question is genuinely open: intermittent application has outperformed standard icing for pain [1], yet continuous cryotherapy has outperformed intermittent after surgery [2], and controlled, maintained peri-operative hypothermia (cryocompression) has reduced inflammatory markers and improved early range of motion after knee replacement [8]. Over-cooling is not free either — chronic post-exercise cooling can blunt training adaptation [6]. The pattern across these results is that outcomes track the temperature actually held, and for how long — precisely the quantity ice neither controls nor records.

The reframe: dose = controlled temperature × time

If the therapeutic agent is a tissue temperature sustained for a period, then the right unit is a dose, not a duration. Stating it that way exposes the two capabilities ice lacks: a rate control, to hold a target temperature without overshooting into the injury range, and a measurement, to know the dose delivered. With both, the clinical question shifts from "how long is safe" to "what tissue temperature, maintained for how long, is optimal for this injury and this phase" — an answerable, empirical question.

What Temp°IQ contributes

The Temp°IQ system provides exactly those two capabilities. Controlled heat extraction is the dial: the device targets and holds a setpoint rather than dumping maximal cold. Onboard calorimetry and tissue-temperature sensing are the meter: the system reports heat removed — in watts and kilojoules — and the tissue temperature achieved, continuously, per session. For the first time a prescribed dose can be both delivered and recorded, making cryotherapy auditable and, crucially, studyable.

Proposed study — mapping the cold dose–response

We propose a controlled study comparing standard interval icing against controlled continuous cooling held at defined target tissue temperatures, with delivered dose measured in every arm.

Arms — standard interval ice (control); controlled continuous cooling at two or more target temperatures (a milder and a deeper setpoint); an instrumented subset capturing the calorimetric dose.
Endpoints — pain, swelling, range of motion, and function over the recovery window; inflammatory biomarkers and return-to-activity where applicable.
Aim — establish a dose–response relationship: the tissue temperature and duration that optimize each endpoint, rather than testing a single fixed protocol.

The design directly addresses the gaps the reviews identify — unmeasured delivered temperature, and unknown optimal mode and duration [2,3].

Open questions we intend to test, not assume

Honesty requires naming what a dial does not settle. Some rationale for limiting cooling is physiological, not tool-bound: inflammation is part of repair, and excessive or prolonged cooling may impede it [6]; reactive hyperemia and the divergence between skin and deep-tissue temperature complicate any single setpoint. A controlled, measured device does not assume these away — it is the instrument that lets them be tested directly, because the delivered temperature and energy are finally known.

The differentiator is not the cooling — it is the measurement.

Why it matters

Dose-controlled cold therapy turns a centuries-old ritual [7] into a measured, titratable intervention, and produces the first empirical cold dose–response curve. It is a claim no cold-plus-compression wearable can make, because the differentiator is not the cooling — it is the measurement.

This paper supports the continuous clinical evaluation of the Temp°IQ system for increased precision and safety. The system measures temperature and energy and supports clinician-directed protocols; it does not diagnose or prescribe, and nothing here is a treatment claim.

References

Take part in the study →Discuss this paper in the forum →